Literature DB >> 16086746

The double-RNA-specific adenosine deaminase (DSRAD) gene in dyschromatosis symmetrica hereditaria patients: two novel mutations and one previously described.

X-K Sun1, A-E Xu, J-F Chen, X Tang.   

Abstract

BACKGROUND: Dyschromatosis symmetrica hereditaria (DSH, MIM 127400) is an autosomal dominant pigmentary genodermatosis. Pathogenic mutations in the double-RNA-specific adenosine deaminase (DSRAD) gene encoding an RNA editing enzyme have recently been identified.
OBJECTIVES: To identify gene mutations of DSRAD in Chinese patients with DSH.
METHODS: Three unrelated Chinese patients with DSH were subjected to mutation detection in DSRAD. Two had family histories of DSH. All the coding exons and their flanking sequences were amplified and sequenced.
RESULTS: All three patients had heterozygous mutations including one non-sense, one frameshift and one missense mutation in DSRAD.
CONCLUSIONS: Two novel mutations, c.3169delC (p.L1057fs) and c.3247C-->T (p.R1083C), and one recurrent mutation c.1420C-->T (p.R474X), were found in this series of Chinese patients with DSH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086746     DOI: 10.1111/j.1365-2133.2005.06572.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

Review 1.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

2.  Analysis of genotype/phenotype correlations in Japanese patients with dyschromatosis symmetrica hereditaria.

Authors:  Tomoko Kobayashi; Michihiro Kono; Mutsumi Suganuma; Hirotaka Akita; Ayaka Takai; Kiyohiro Tsutsui; Yu Inasaka; Takuya Takeichi; Yoshinao Muro; Masashi Akiyama
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.